{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "exchange": "FRA", "shortName": "N4 PHARMA PLC -,004", "longName": "N4 Pharma Plc", "messageBoardId": "finmb_283400218", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketChangePercent": -16.66667, "regularMarketPrice": 0.01, "marketState": "REGULAR", "firstTradeDateMilliseconds": 1611558000000, "priceHint": 4, "epsTrailingTwelveMonths": -0.01, "sharesOutstanding": 233780000, "bookValue": 0.009, "fiftyDayAverage": 0.01171, "fiftyDayAverageChange": -0.0017100004, "fiftyDayAverageChangePercent": -0.14602907, "twoHundredDayAverage": 0.0140575, "twoHundredDayAverageChange": -0.0040575005, "twoHundredDayAverageChangePercent": -0.288636, "marketCap": 4083430, "priceToBook": 1.1111112, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "regularMarketChange": -0.0020000003, "regularMarketTime": 1683872766, "regularMarketDayHigh": 0.01, "regularMarketDayRange": "0.01 - 0.01", "regularMarketDayLow": 0.01, "regularMarketVolume": 600, "regularMarketPreviousClose": 0.012, "bid": 0.0105, "ask": 0.041, "fullExchangeName": "Frankfurt", "financialCurrency": "GBP", "regularMarketOpen": 0.01, "averageDailyVolume3Month": 0, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 0.0019999994, "fiftyTwoWeekLowChangePercent": 0.24999991, "fiftyTwoWeekRange": "0.008 - 0.057", "fiftyTwoWeekHighChange": -0.047, "fiftyTwoWeekHighChangePercent": -0.82456136, "fiftyTwoWeekLow": 0.008, "fiftyTwoWeekHigh": 0.057, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "symbol": "0GO.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "60 Gracechurch Street", "address2": "6th Floor", "city": "London", "zip": "EC3V 0HR", "country": "United Kingdom", "phone": "44 1332 690061", "website": "https://www.n4pharma.com", "industry": "Drug Manufacturers\u2014Specialty & Generic", "industryDisp": "Drug Manufacturers\u2014Specialty & Generic", "sector": "Healthcare", "longBusinessSummary": "N4 Pharma Plc, a specialist pharmaceutical company, develops silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom. It develops Nuvec, a non-viral adjuvant delivery system for vaccines and cancer treatments. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom.", "fullTimeEmployees": 5, "companyOfficers": [{"maxAge": 1, "name": "Mr. Nigel James Theobald", "age": 58, "title": "Founder, CEO & Exec. Director", "yearBorn": 1964, "fiscalYear": 2022, "totalPay": {"raw": 97732, "fmt": "97.73k", "longFmt": "97,732"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. David  Templeton", "title": "Exec. Director & Technical Director", "fiscalYear": 2022, "totalPay": {"raw": 58639, "fmt": "58.64k", "longFmt": "58,639"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Luke Sebastian Cairns", "age": 44, "title": "Exec. Director", "yearBorn": 1978, "fiscalYear": 2022, "totalPay": {"raw": 52123, "fmt": "52.12k", "longFmt": "52,123"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Rob  Harris", "title": "Head of CMC Devel.", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Andrew  Leishman", "title": "Consultant", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}